Literature DB >> 17629776

Brain drug development and brain drug targeting.

William M Pardridge.   

Abstract

Mesh：

Year:  2007        PMID： 17629776     DOI： 10.1007/s11095-007-9387-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  17 in total

1.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

2.  Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders.

Authors:  Yeon-Joo Kang; Murat Digicaylioglu; Rossella Russo; Marcus Kaul; Cristian L Achim; Lauren Fletcher; Eliezer Masliah; Stuart A Lipton
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

Review 3.  Challenges in design and characterization of ligand-targeted drug delivery systems.

Authors:  Silvia Muro
Journal:  J Control Release       Date:  2012-06-15       Impact factor: 9.776

4.  Poly(ε-caprolactone)-block-poly(ethyl ethylene phosphate) micelles for brain-targeting drug delivery: in vitro and in vivo valuation.

Authors:  Pengcheng Zhang; Luojuan Hu; Yucai Wang; Jun Wang; Linyin Feng; Yaping Li
Journal:  Pharm Res       Date:  2010-09-18       Impact factor: 4.200

Review 5.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

6.  Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous system.

Authors:  Jana Zdarova Karasova; Filip Zemek; Kamil Musilek; Kamil Kuca
Journal:  Neurotox Res       Date:  2012-05-15       Impact factor: 3.911

7.  Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood-brain barrier and enhance doxorubicin antiglioma effect.

Authors:  Yuling Li; Li Baiyang; Bu Leran; Wang Zhen; Xie Yandong; Du Baixiang; Zhu Dandan; Zhu Yufu; Liang Jun; Yu Rutong; Liu Hongmei
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Modulating Expression of Endogenous Interleukin 1 Beta in the Acute Phase of the Pilocarpine Model of Epilepsy May Change Animal Survival.

Authors:  R B Marchesini; V D B Pascoal; M C P Athié; A H B Matos; F F Conte; T C Pereira; R Secolin; R Gilioli; J M Malheiros; R S Polli; A Tannús; L Covolan; L B Pascoal; A S Vieira; E A Cavalheiro; F Cendes; I Lopes-Cendes
Journal:  Cell Mol Neurobiol       Date:  2022-01-21       Impact factor: 5.046

9.  A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development.

Authors:  Jing Xie; Eric Farage; Masahiko Sugimoto; Bela Anand-Apte
Journal:  BMC Dev Biol       Date:  2010-07-23       Impact factor: 1.978

10.  Discovery of a Highly Conserved Peptide in the Iron Transporter Melanotransferrin that Traverses an Intact Blood Brain Barrier and Localizes in Neural Cells.

Authors:  Chaahat S B Singh; Brett A Eyford; Thomas Abraham; Lonna Munro; Kyung Bok Choi; Mark Okon; Timothy Z Vitalis; Reinhard Gabathuler; Chieh-Ju Lu; Cheryl G Pfeifer; Mei Mei Tian; Wilfred A Jefferies
Journal:  Front Neurosci       Date:  2021-06-02       Impact factor: 4.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.